FHTX

6.65 +0.91%
Foghorn Therapeutics Inc. NASDAQ Stock Pharmaceutical Stocks
Open in Risen →

Foghorn Therapeutics Inc. (FHTX) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time FHTX price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.

Technical Analysis

RSI (14) 71.5 Overbought
Market Cap $394.9M
Volume 174.7K

Fundamentals — 10-Q Q2 2026

Revenue $19.3M
Net Income $-27.1M
EPS $-0.39
Operating Margin -157.1%
Net Margin -140.0%
P/E Ratio -17.1x

Earnings

Recent Insider Trades

Name Title Type Shares Price Value Date
Costa Carlos Chief People Officer Sell 36,613 $10.04 $367,706 2024 Sep 23
Costa Carlos Chief People Officer Sell 11,574 $10.05 $116,319 2024 Sep 18
Costa Carlos Chief People Officer Sell 10,672 $10.04 $107,131 2024 Sep 17
Bellon Steven F. Chief Scientific Officer Sell 20,000 $9.50 $190,000 2024 Sep 9
Cavalie Fanny Chief Strategy/Bus Ops Officer Sell 11,000 $6.56 $72,160 2024 Mar 11
Agresta Samuel Chief Medical Officer Sell 311,297 $8.25 $2.6M 2023 Aug 16
Flagship Ventures Fund V, L.P. 10% Owner Buy 150,000 $16.00 $2.4M 2020 Oct 27
Decicco Carl Chief Scientific Officer Buy 5,500 $16.00 $88,000 2020 Oct 27
Platinum Falcon B 2018 RSC Ltd Insider Buy 150,000 $16.00 $2.4M 2020 Oct 27

Take FHTX further

Set alerts on FHTX

Get notified when Foghorn Therapeutics Inc. hits your price targets or technical conditions are met.

Get Started Free